Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT03666351

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03666351
Other papers using this trial's data
  • Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease American heart journal, 2024-02 DOI, PubMed 38006908

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03666351. Randomized; single masking; primary purpose treatment. Start 2018-10-18 (actual); primary completion 2022-07-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
Condition
Aortic Stenosis
Condition
Aortic Regurgitation
Condition
Hypertension
Condition
LVM
Condition
Left Ventricular Hypertrophy
Intervention (Drug)
Amlodipine 5mg
Intervention (Drug)
Losartan
Intervention (Drug)
Losartan and Amlodipine
Intervention (Drug)
Amlodipine/Losartan/Chlorthalidone
Intervention (Drug)
current treatment
Lead sponsor
Hanmi Pharmaceutical Company Limited (class: industry)

Record details

Record id
cardio:ct-nct03666351
Content hash
fe3294a9e28f529d0762876c3b7314676e1c6896d6438236bc98aee7555e4d88